Ovarian cancer
Results
Phase 2
This trial looked at having olaparib in combination with chemotherapy followed by olaparib on its own.
It was for women with the most common type of ovarian cancer ( serous type epithelial ovarian cancer) that had come back after treatment with a .
This trial closed in 2010. These results were published in 2015.
Recruitment start: 28 February 2010
Recruitment end: 30 June 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Amit Oza
AstraZeneca
Last reviewed: 8 June 2021
CRUK internal database number: 6069
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
